Glaxo and Teva settle Lamictal suit

home   >   blogdigger

GlaxoSmithKline and generics giant Teva Pharmaceutical Industries have settled patent litigation relating to lamotrigine, the generic version of GlaxoSmithKline's bipolar disorder and epilepsy drug, Lamictal.

- link to Glaxo and Teva settle Lamictal suit -
Last update: 05/26/2005

Recommended Reading

    Life-threatening reactions reported with anticonvulsant lamotrigine. (Also Confused With Other Drugs). : An article from: Skin & Allergy News
    Lamictal: (lamotrigine, GlaxoSmithKline).(New & approved: pravigard PAC, Lamictal) : An article from: Internal Medicine News
    Lamictal: (lamotrigine, GlaxoSmithKline).(New & approved: pravigard PAC, Lamictal) : An article from: Internal Medicine News
    Pravigard pac: (copackaged pravastatin sodium and bufered aspirin tablets, Bristol-Myers Squibb).(New & approved: pravigard PAC, Lamictal) : An article from: Internal Medicine News
    Life-threatening reactions reported with anticonvulsant lamotrigine. (Also Confused With Other Drugs). : An article from: Skin & Allergy News
    Lamictal.(New & Approved)(lamotrigine from GlaxoSmithKline)(Brief Article) : An article from: Family Practice News
    Life-threatening reactions reported with anticonvulsant lamotrigine. (Also Confused With Other Drugs). : An article from: Skin & Allergy News
    Pravigard pac: (copackaged pravastatin sodium and bufered aspirin tablets, Bristol-Myers Squibb).(New & approved: pravigard PAC, Lamictal) : An article from: Internal Medicine News